United States · FDA National Drug Code directory
glycopyrrolate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71656-061_26be665a-acae-22fd-e063-6394a90a2a0e
- Product NDC
- 71656-061
- Form
- SOLUTION
- Composition / generic term
- glycopyrrolate
- Labeler
- Saptalis Pharmaceuticals, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241125
- Source listing expiry
- 20261231
Source-listed ingredients
- GLYCOPYRROLATE — 1 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOTTLE (71656-061-16) / 473 mL in 1 BOTTLE · 71656-061-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →